Protocol summary

Study aim
Comparison of the effects of Fentanyl-Bbupivacaine and Sufentanil-Bbupivacaine
Design
Clinical trial with a control group, with parallel groups, three blinded, randomized, phase 2 on 105 patients. A lottery will be used for randomization.
Settings and conduct
This is a three-blind randomized clinical trial conducted on 105 patients candidate for lower limb surgery under spinal anesthesia in Kashani and Al-Zahra hospitals in Isfahan. After the ethics committee's approval and obtaining the patient's consent, the patients are randomly assigned into groups, the desired intervention is applied in each group, and the patient's clinical symptoms are recorded. The researcher who registers and collects data and the data analyst are not aware of the type of intervention applied. although the patients are included in the study, they are not aware of the type of intervention applied and therefore they are all blind.
Participants/Inclusion and exclusion criteria
Inclusion criteria: patients over 18 years old, candidate for lower limb surgery under spinal anesthesia, ASA anesthesia class I and II, informed consent to participate in the study Non-entry criteria: infection at the injection site, coagulation disorders, high intracranial pressure, drug addiction, and BMI over 30.
Intervention groups
Intervention group A: Patients in this group receive 3 ml of Ropivacaine 0.5% along with 25 micrograms of Fentanyl (0.5 CC from the ampoule) for spinal anesthesia. Intervention group B: Patients in this group receive 3 ml of Ropivacaine 0.5% along with 25 micrograms of Sufentanil (0.5 CC from the ampoule) for spinal anesthesia. Control group C: Patients in this group receive 3 ml of 0.5% Ropivacaine along with 0.5 CC of distilled Water for spinal anesthesia.
Main outcome variables
Time of sensory and motor block effect; the time to reach the maximum sensory and motor block; Duration of sensory and motor block

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20081013001328N2
Registration date: 2022-09-06, 1401/06/15
Registration timing: registered_while_recruiting

Last update: 2022-09-06, 1401/06/15
Update count: 0
Registration date
2022-09-06, 1401/06/15
Registrant information
Name
mohammad ali vakili
Name of organization / entity
esfahan medical university
Country
Iran (Islamic Republic of)
Phone
+98 31 1440 1685
Email address
montazeri@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-07-23, 1401/05/01
Expected recruitment end date
2022-10-23, 1401/08/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of administration of Ropivacaine-Fentanyl and Ropivacaine-Sufentanil combination on the characteristics of sensory and motor block in lower limb surgery under spinal anesthesia
Public title
Comparison of the effect of Ropivacaine-Fentanyl and Ropivacaine-Sufentanil administration on spinal anesthesia
Purpose
Diagnostic
Inclusion/Exclusion criteria
Inclusion criteria:
Age 18 years and above Candidate for lower limb surgery under spinal anesthesia ASA class I and II informed consent to enter the study
Exclusion criteria:
Infection at the injection site Coagulation disorders and the use of anticoagulants Suffering from high intracranial pressure Drug addiction Patients with body mass index (BMI) above 30
Age
From 18 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Investigator
  • Outcome assessor
  • Data analyser
Sample size
Target sample size: 105
Randomization (investigator's opinion)
Randomized
Randomization description
This is a simple randomized clinical trial in which patients enter the study groups by lottery; The medicines and placebo are placed in the sealed, opaque, and similar form packets coded. Each code is also written on a piece of paper, folded, and placed inside a box. After entering the operating room, each patient takes one of the papers out of the box; The pocket with the same number is the intervention that will apply to him. This process continues till the number of patients reaches the desired one.
Blinding (investigator's opinion)
Triple blinded
Blinding description
This is a three-blind clinical trial; In this way, before obtaining consent, the patients will be included in the study, but they do not know which group they will be in, and therefore they are blind. The researcher who records the patient's symptoms and collects the data related to the outcome variables, and also the person who analyzes the data collected during the study, do not know the type of intervention applied and therefore they are all blind.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee in Biomedical Research, Isfahan University of Medical Sciences
Street address
Hezar Jarib St
City
Isfahan
Province
Isfehan
Postal code
8174673461
Approval date
2022-02-10, 1400/11/21
Ethics committee reference number
IR.MUI.MED.REC.1400.798

Health conditions studied

1

Description of health condition studied
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
The time to onset of the numbing
Timepoint
Every 30 seconds from the moment of injection to the first feeling of numbing at the level of the L4 vertebra
Method of measurement
Pinprick and Timer

2

Description
Duration of reaching the maximum level of numbing
Timepoint
Every 30 seconds from the moment of injection to numbing of the T12 vertebra surface
Method of measurement
Pinprick and Timer

3

Description
Duration of return of numbing
Timepoint
From the time of drug injection until the return of sensation at S1 level
Method of measurement
Pinprick and Timer

Secondary outcomes

1

Description
Blood Pressure
Timepoint
before the injection, 3, 5, and 10 minutes after the spinal and then every 15 minutes until the end of recovery
Method of measurement
Sphymomanmeter

2

Description
Heart Rate
Timepoint
before the injection, 3, 5, and 10 minutes after the spinal and then every 15 minutes until the end of recovery
Method of measurement
ECG monitoring

3

Description
Oxygen Saturation
Timepoint
From the moment of entering the operating room until the end of recovery
Method of measurement
Pulse Oximeter

Intervention groups

1

Description
Intervention group A: Patients in this group are sedated with fentanyl prodrugs at a dose of 1 µg/kg and Midazolam at a dose of 20 µg/kg after monitoring and fluid therapy, and oxygen with a flow of 6-8 liters is established for the patient. Then they receive 3 ml of Ropivacaine 0.5% made by Sinadaro company along with 25 micrograms (equivalent to 0.5cc) of Fentanyl made by Caspin Pharmaceutical Company for spinal anesthesia.
Category
Diagnosis

2

Description
Intervention group B: Patients in this group are sedated with fentanyl prodrugs at a dose of 1 µg/kg and Midazolam at a dose of 20 µg/kg after monitoring and fluid therapy, and oxygen with a flow of 6-8 liters is established for the patient. Then they receive 3 ml of Ropivacaine 0.5% made by Sinadaro company along with 2.5 micrograms (equivalent to 0.5cc) of Sufentanyl made by Caspin Pharmaceutical Company for spinal anesthesia.
Category
Diagnosis

3

Description
Control group C: Patients in this group are sedated with fentanyl prodrugs at a dose of 1 µg/kg and Midazolam at a dose of 20 µg/kg after monitoring and fluid therapy, and oxygen with a flow of 6-8 liters is established for the patient. Then they receive 3 ml of Ropivacaine 0.5% made by Sinadaro company along with 0.5cc of distilled water made by Caspian pharmaceutical company for spinal anesthesia.
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Alzahra hospital
Full name of responsible person
Kamran Montazeri
Street address
Soffeh boulevard, Shahid Keshvari highway
City
Isfahan
Province
Isfehan
Postal code
8174675731
Phone
+98 31 3620 2020
Email
montazeri@med.mui.ac.ir

2

Recruitment center
Name of recruitment center
kashani hospital
Full name of responsible person
Kamran Montazeri
Street address
Kashani Ave.
City
Isfahan
Province
Isfehan
Postal code
8183983434
Phone
+98 31 3233 0091
Email
montazeri@med.mui.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Shaghayegh Haghjoo
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 0048
Email
research@mui.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Esfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Emad Khan ahmad
Position
Professor Assistant
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
Hezar Jarib St
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3662 0048
Email
Emad.khanahmad@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Kamran Montazeri
Position
Anesthesiologist/Faculty
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8174673461
Phone
+98 31 3668 8597
Email
montazeri@med.mui.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Esfahan University of Medical Sciences
Full name of responsible person
Leyla Rafiei
Position
Nurse Anesthetist
Latest degree
Bachelor
Other areas of specialty/work
Anesthesiology
Street address
Hezar Jarib
City
Isfahan
Province
Isfehan
Postal code
8146713543
Phone
+98 31 3620 2020
Email
Leylarafiei943@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Loading...